![](/img/cover-not-exists.png)
Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil)
N. Hatam, N. Ahmadloo, A. Ahmad Kia Daliri, P. Bastani, M. AskarianVolume:
284
Language:
english
Pages:
6
DOI:
10.1007/s00404-010-1609-8
Date:
July, 2011
File:
PDF, 178 KB
english, 2011